Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases
Author:
- 1 August 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 21 (4) , 337-345
Abstract
The purpose of this review is to provide insights into recent advances in mechanisms linking apolipoprotein (apo) E isoforms to cardiovascular and neurological diseases. Human apoE has three common isoforms (apoE2, apoE3, and apoE4) with different structural and biophysical properties and different effects on lipid and neuronal homeostasis. ApoE is a protein constituent of different plasma lipoproteins and serves as a high-affinity ligand for several receptors. By interacting with its receptors, apoE mediates the clearance of different lipoproteins from the circulation. Absence or structural mutations of apoE cause significant disorders in lipid metabolism and cardiovascular disease. ApoE also has significant roles in neurobiology. ApoE4 is the major known genetic risk factor for Alzheimer's disease. It increases the occurrence and lowers the age of onset of Alzheimer's disease. ApoE4 carriers account for 65-80% of all Alzheimer's disease cases, highlighting the importance of apoE4 in Alzheimer's disease pathogenesis. ApoE4 has both amyloid beta-dependent and amyloid beta-independent roles in Alzheimer's disease pathogenesis. Emerging data suggest that apoE isoforms, with their multiple cellular origins and multiple structural and biophysical properties, contribute to cardiovascular and neurological diseases by interacting with different factors through various pathways.Keywords
This publication has 109 references indexed in Scilit:
- GABAergic Interneuron Dysfunction Impairs Hippocampal Neurogenesis in Adult Apolipoprotein E4 Knockin MiceCell Stem Cell, 2009
- Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte FunctionJournal of Biological Chemistry, 2009
- Apolipoprotein E4 (1–272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cellsMolecular Neurodegeneration, 2009
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- Understanding the Association of Apolipoprotein E4 with Alzheimer Disease: Clues from Its StructureJournal of Biological Chemistry, 2009
- Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neuronsProceedings of the National Academy of Sciences, 2008
- Phosphorylation state of tau in the hippocampus of apolipoprotein E4 and E3 knock-in miceNeuroReport, 2003
- Increased Expression of Neuronal Apolipoprotein E in Human Brain With Cerebral InfarctionStroke, 2003
- Deficiency in Mitochondrial Aldehyde Dehydrogenase Increases the Risk for Late-Onset Alzheimer's Disease in the Japanese PopulationBiochemical and Biophysical Research Communications, 2000
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993